Second Opinion: Laetrile at Sloan Kettering
Eric Merola (2014)
Second Opinion is a documentary about the deliberate cover-up of an alternative cancer treatment by Sloan Kettering Cancer Center, America’s foremost cancer research institution, and Dr Robert Moss, the Sloan Kettering science writer who exposed the cover-up.
As strange as it may seem Sloan Kettering themselves did the definitive research showing that Laetrile (aka Amygdalin and B17) is effective in small tumors in early stage cancer. Sloan Kettering even went so far as to apply to the FDA (in 1974 and 1975) for permission to conduct human Laetrile trials.
A year later, under massive pressure from the National Cancer Institute and American Cancer Society (both receive major funding from Big Pharma), the top brass at Sloan Kettering reversed…
View original post 432 more words